<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pediatr Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pediatr Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">pde</journal-id>
      <journal-title-group>
        <journal-title>Pediatric Dermatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0736-8046</issn>
      <issn pub-type="epub">1525-1470</issn>
      <publisher>
        <publisher-name>Blackwell Publishing Ltd</publisher-name>
        <publisher-loc>Oxford, UK</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22515571</article-id>
      <article-id pub-id-type="pmc">3709244</article-id>
      <article-id pub-id-type="doi">10.1111/j.1525-1470.2012.01757.x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical and Laboratory Investigations</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>An Incompletely Penetrant Novel Mutation in <italic>COL7A1</italic> Causes Epidermolysis Bullosa Pruriginosa and Dominant Dystrophic Epidermolysis Bullosa Phenotypes in an Extended Kindred</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Catherine S</given-names>
          </name>
          <degrees>BA</degrees>
          <xref ref-type="aff" rid="au1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Yin</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="au2">&#x2020;</xref>
          <xref ref-type="aff" rid="au4">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Farhi</surname>
            <given-names>Anita</given-names>
          </name>
          <degrees>RN</degrees>
          <xref ref-type="aff" rid="au2">&#x2020;</xref>
          <xref ref-type="aff" rid="au4">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nelson-Williams</surname>
            <given-names>Carol</given-names>
          </name>
          <degrees>B.S.</degrees>
          <xref ref-type="aff" rid="au2">&#x2020;</xref>
          <xref ref-type="aff" rid="au4">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kashgarian</surname>
            <given-names>Michael</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="au3">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Glusac</surname>
            <given-names>Earl J</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="au1">*</xref>
          <xref ref-type="aff" rid="au3">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lifton</surname>
            <given-names>Richard P</given-names>
          </name>
          <degrees>M.D., Ph.D.</degrees>
          <xref ref-type="aff" rid="au2">&#x2020;</xref>
          <xref ref-type="aff" rid="au4">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Antaya</surname>
            <given-names>Richard J</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="au1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choate</surname>
            <given-names>Keith A</given-names>
          </name>
          <degrees>M.D., Ph.D.</degrees>
          <xref ref-type="aff" rid="au1">*</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <aff id="au1">
          <label>*</label>
          <institution>Department of Dermatology</institution>
        </aff>
        <aff id="au2">
          <label>&#x2020;</label>
          <institution>Department of Genetics</institution>
        </aff>
        <aff id="au3">
          <label>&#x2021;</label>
          <institution>Department of Pathology</institution>
        </aff>
        <aff id="au4">
          <label>&#xA7;</label>
          <institution>Howard Hughes Medical Institute, School of Medicine, Yale University</institution>
          <addr-line>New Haven, Connecticut</addr-line>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address correspondence to Keith Choate, M.D., Ph.D., Department of Dermatology, 333 Cedar Street, New Haven, CT 06510, USA, or e-mail: <email>keith.choate@yale.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>4</month>
        <year>2012</year>
      </pub-date>
      <volume>29</volume>
      <issue>6</issue>
      <fpage>725</fpage>
      <lpage>731</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2012 Wiley Periodicals, Inc.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Epidermolysis bullosa pruriginosa (EBP) is a rare subtype of dystrophic epidermolysis bullosa (DEB) characterized by intense pruritus, nodular or lichenoid lesions, and violaceous linear scarring, most prominently on the extensor extremities. Remarkably, identical mutations in <italic>COL7A1,</italic> which encodes an anchoring fibril protein present at the dermal&#x2013;epidermal junction, can cause both DEB and EBP with either autosomal dominant or recessive inheritance. We present one family with both dystrophic and pruriginosa phenotypes of epidermolysis bullosa. The proband is a 19-year-old Caucasian woman who initially presented in childhood with lichenoid papules affecting her extensor limbs and intense pruritus consistent with EBP. Her maternal grandmother saw a dermatologist for similar skin lesions that developed without any known triggers at age 47 and mostly resolved spontaneously after approximately 10 years. The proband&#x2019;s younger brother developed a small crop of pruritic papules on his elbows, dorsal hands, knees, and ankles at age 13. Her second cousin once removed, however, reported a mild blistering disease without pruritus consistent with DEB. Genetic sequencing of the kindred revealed a single dominant novel intron 47 splice site donor G&gt;A mutation, c.4668 + 1 G&gt;A, which we predict leads to exon skipping. Incomplete penetrance is confirmed in her clinically unaffected mother, who carries the same dominant mutation. The wide diversity of clinical phenotypes with one underlying genotype demonstrates that <italic>COL7A1</italic> mutations are incompletely penetrant and strongly suggests that other genetic and environmental factors influence clinical presentation.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Dystrophic epidermolysis bullosa (DEB) is a clinically heterogenous class of diseases characterized by the formation of trauma-induced blistering at the sub-lamina densa level. Epidermolysis bullosa pruriginosa (EBP), first described by McGrath and colleagues in 1994 (<xref ref-type="bibr" rid="b1">1</xref>), is a rare subtype of DEB distinguished by intense pruritus, lichenified or nodular prurigo-like lesions, and violaceous linear scarring, most notably on the extensor extremities. Excoriations, milia, nail dystrophy, and albopapuloid lesions are often seen. Teeth and mucous membranes are usually unaffected. Although some cases of EBP are diagnosed within the first few years of life, many cases do not present until adulthood (<xref ref-type="bibr" rid="b2">2</xref>&#x2013;<xref ref-type="bibr" rid="b7">7</xref>). As such, EBP can be mistaken for acquired disorders such as prurigo nodularis, lichen simplex chronicus, lichen planus, hypertrophic scarring, and dermatitis artefacta.</p>
    <p>Dominant and recessive mutations in the gene <italic>COL7A1</italic> encoding for collagen VII have been reported to cause DEB. Collagen VII is the major anchoring fibril located below the basal lamina, at the dermal&#x2013;epidermal junction. Dominantly inherited DEB typically presents with milder clinical symptoms and shows normal quantity and appearance of anchoring fibrils on biopsy. Recessive DEB is often more severe and usually results from premature termination codon mutations leading to decreased amounts of collagen VII apparent on electron microscopy and immunofluorescence staining.</p>
    <p>The cause of pruritus in EBP is unknown. Attempts to correlate genotype with phenotype have been unsuccessful (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b10">10</xref>), since identical mutations in <italic>COL7A1</italic> can cause DEB in one patient and EBP in another (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b11">11</xref>&#x2013;<xref ref-type="bibr" rid="b13">13</xref>). Alternate hypotheses regarding the origin of pruritus have included high serum immunoglobulin (Ig)E levels (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b24">24</xref>), concurrent filaggrin mutations leading to atopy (<xref ref-type="bibr" rid="b7">7</xref>), high expression of matrix metalloproteinase 1 (<italic>MMP1</italic>) causing imbalance of collagen degradation (<xref ref-type="bibr" rid="b16">16</xref>,<xref ref-type="bibr" rid="b2">18</xref>), and high cytokine interleukin (IL)-31 levels (<xref ref-type="bibr" rid="b10">10</xref>). None of these hypotheses uniformly account for pruritus observed in EBP.</p>
    <p>We studied one kindred with both EBP and DEB phenotypes (<xref ref-type="fig" rid="fig01">Fig. 1</xref>). The proband is a 19-year-old woman of Italian descent who was referred to our clinic at age 5 with new-onset pruritic lesions on her right medial malleolus and chin. Over time, her pruritus gradually worsened, with extension of lesions to her extensor extremities bilaterally, the periumbilicus, the sacrum, and the upper back. No triggers were reported. She was otherwise healthy, without a history of atopy. Her parents are non-consanguineous, and neither reported any history of atopy, skin fragility, or pruritic dermatoses. The proband&#x2019;s grandmother developed similar lesions at age 47 that persisted for approximately 10 years before mostly resolving spontaneously. The proband&#x2019;s 15-year-old brother also developed pruritic papules at age 13 but was much less affected. Meanwhile, her second cousins once removed and their father reported only trauma-induced blistering. The objective of this study was to better characterize the genetic complexity of <italic>COL7A1</italic> mutations causing DEB and EBP in this kindred.</p>
    <fig id="fig01" position="float">
      <label>Figure 1</label>
      <caption>
        <p>DEB and EBP phenotypes independently segregate in one kindred with incomplete penetrance. Individuals in EBP kindred 100 show either an epidermolysis bullosa pruriginosa phenotype (black symbols) or a dominant dystrophic epidermolysis bullosa phenotype (gray symbols). *Indicates genetic analysis has been performed.</p>
      </caption>
      <graphic xlink:href="pde0029-0725-f1"/>
    </fig>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>The Human Investigation Committee at Yale University approved the study protocol. Dermatologists clinically examined the proband, her immediate family members, and two members of her extended family (100&#x2013;6, 100&#x2013;7) between 1997 and 2011. In the proband, clinical diagnosis was verified with skin biopsies of lesional sites. IgE levels, thyroid function, renal function, liver function, iron, and ferritin were tested in the proband to exclude alternative causes of pruritus. Two family members reported to have DEB were unable to participate in this study (100&#x2013;8, 100&#x2013;9).</p>
      <p>Genomic DNA was extracted from peripheral blood lymphocytes in the proband and immediate family members using phenol-chloroform extraction. Primer sets representing all 118 exons of <italic>COL7A1</italic>, including intron&#x2013;exon boundaries, were generated with Primer3 (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/primer3/">http://frodo.wi.mit.edu/primer3/</ext-link>) using the hg18 version of the genome masked to exclude DNA sequence repeats (GenomeMasker: <ext-link ext-link-type="uri" xlink:href="http://bioinfo.ebc.ee/snpmasker/">http://bioinfo.ebc.ee/snpmasker/</ext-link>) as the template. We also generated primers for the five most common filaggrin mutations in European populations (R501X, 2282del4, 3702delG, R2447X, and S3247X) (<xref ref-type="bibr" rid="b17">17</xref>) and for the previously reported promoter single-nucleotide polymorphism (SNP) in <italic>MMP1</italic> [rs1799750: (&#x2212;)&gt;G] hypothesized to account for the pruritus of EBP (<xref ref-type="bibr" rid="b18">18</xref>). Polymerase chain reaction was conducted on 50 ng of DNA using KAPA2G Fast Polymerase (Kapa Biosystems, Woburn, MA) and its products were sequenced. Resulting sequences were compared with the human reference sequence (hg18, NCBI) using Sequencher (Gene Codes, Ann Arbor, MI). A single sequence variant in <italic>COL7A1</italic> was identified that was not found in SNP databases or in 95 ethnically matched unrelated controls without a history of skin disease.</p>
      <p>Review of the literature for <xref ref-type="supplementary-material" rid="SD1">Table S1</xref> was performed using the PUBMED search term &#x201C;epidermolysis bullosa pruriginosa&#x201D; between June 2009 and October 2011. Forty-two articles were identified; 13 were excluded because the case presented did not have EBP or because no genetic analysis was performed. Additional mutations were found using the Dystrophic EB Patient Registry (<ext-link ext-link-type="uri" xlink:href="http://www.deb-central.org">http://www.deb-central.org</ext-link>). Each mutation was then surveyed using the Human Gene Mutation Database (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.org/">http://www.hgmd.org/</ext-link>) and recent reviews of the <italic>COL7A1</italic> gene (<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b28">28</xref>) to determine whether it had been previously reported to cause DEB. Any discrepancies between sources were resolved by referring to the original article reporting the mutation in question.</p>
    </sec>
    <sec>
      <title>Results</title>
      <p>On full skin examination, the proband displayed excoriated, lichenoid papules with milia coalescing into confluent plaques (<xref ref-type="fig" rid="fig02">Fig. 2</xref>). There was no nail dystrophy, and ancillary laboratory tests to evaluate her pruritus were all within normal limits. Skin tests for common food allergens and standard inhalants were negative except for an allergic reaction to penicillin at age 9. Histopathology of her lesions showed a sub-epidermal cleft with milia. Electron microscopy showed a sub-epidermal cleft with lysis and separation of collagen fibrils in the reticular dermis. There was no evidence of amyloid deposition. Direct immunofluorescence showed normal quantities and immunolocalization patterns of collagen IV, collagen VII, and keratin 14. Taken together, these findings supported a diagnosis of EBP (<xref ref-type="fig" rid="fig03">Fig. 3</xref>).</p>
      <fig id="fig02" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Clinical features of EBP in proband, 100-1. (A-C) Lichenoid papules and nodular prurigo-like lesions on shins bilaterally (A), dorsal hand (B), and upper back (C). Many papules are excoriated.</p>
        </caption>
        <graphic xlink:href="pde0029-0725-f2"/>
      </fig>
      <fig id="fig03" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Histologic features of EBP in proband, 100-1. EBP is characterized by subepidermal clefting and disruption of anchoring fibrils. (A) Hematoxylin and eosin stain of affected skin shows subepidermal clefting (black arrow) and milium, 20X magnification. (B, C) Direct immunofluorescence staining shows normal pattern and amount of collagen IV and VII. (D) Electron microscopy of skin adjacent to a nodular lesion shows lysis and separation of collagen fibrils in the reticular dermis (white arrow). *Indicates subepidermal cleft.</p>
        </caption>
        <graphic xlink:href="pde0029-0725-f3"/>
      </fig>
      <p>The only remnants of EBP in the propositus&#x2019; grandmother were macular scars on her upper back and intermittent clusters of pruritic papules on her upper extremities (<xref ref-type="fig" rid="fig04">Fig. 4A</xref>). The proband&#x2019;s brother had few, isolated pruritic papules on his dorsal hands, elbows, knees, and ankles (<xref ref-type="fig" rid="fig04">Fig. 4B</xref>). The proband&#x2019;s second cousin once removed had trauma-induced blistering, atrophic scarring, and few milia on his extensors (<xref ref-type="fig" rid="fig04">Fig. 4C</xref>).</p>
      <fig id="fig04" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Clinical heterogeneity of EBP and DEB in kindred EBP 100. (A) Cluster of papules on the right hand of the proband&#x2019;s maternal grandmother, 100-6. (B) Lichenoid papules on the left index finger of the proband&#x2019;s 15-year-old brother, 100-4. (C) Blister and atrophic scarring on knee of the proband&#x2019;s second cousin once removed, 100-7.</p>
        </caption>
        <graphic xlink:href="pde0029-0725-f4"/>
      </fig>
      <p>Sanger sequencing of <italic>COL7A1</italic> in this kindred revealed a novel heterozygous splice site mutation in intron 47, c.4668 + 1 G&gt;A, in the proband, her affected family members, and her unaffected mother. This mutation abolishes the intron 47 splice donor; similar mutations frequently lead to exon skipping or use of cryptic splice sites nearby (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b27">27</xref>,<xref ref-type="bibr" rid="b28">28</xref>). Sixty-two mutations causing EBP are reviewed in <xref ref-type="fig" rid="fig05">Fig. 5</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>. All of the dominant mutations, including c.4668 + 1 G&gt;A, interfere with the consecutive Gly-X-Y repeats in the triple helical domain of the protein. Ten recessive cases were identified and are summarized in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>.</p>
      <fig id="fig05" position="float">
        <label>Figure 5</label>
        <caption>
          <p><italic>COL7A1</italic> mutations reported to cause EBP. Fifty-seven mutations are represented. Missense and nonsense mutations are represented using the protein sequence whereas splicing mutations, deletions, and insertions are represented using the cDNA sequence. The mutation identified in this family is bolded and denoted by an asterisk. Recessive mutations appear above the protein schematic and dominant mutations appear below.</p>
        </caption>
        <graphic xlink:href="pde0029-0725-f5"/>
      </fig>
      <p>Recognizing that filaggrin mutations could modify the phenotypes observed in this kindred (<xref ref-type="bibr" rid="b17">17</xref>), we performed sequencing of the five most common <italic>FLG</italic> variants in the European population in our patient and found none. We also addressed the findings of another group who suggested that a promoter SNP in <italic>MMP1</italic> leads to overexpression thus causing an imbalance of collagen degradation, with ensuing inflammation and pruritus, but sequencing of the proposed transcription factor binding site [rs1799750: (&#x2212;)&gt;G] of <italic>MMP1</italic> did not reveal any sequence differences between the proband and her mother.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>No clear pattern emerges from attempts to correlate <italic>COL7A1</italic> gene mutations with disease phenotype (<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b10">10</xref>,<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b29">29</xref>). Most of the mutations in EBP are dominant, and many of the reported recessive cases may include a silent mutation or SNP in addition to a presumably causative coding mutation (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). Incomplete penetrance is well documented in reports of unaffected family members carrying the same mutations as their affected relatives (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b13">13</xref>,<xref ref-type="bibr" rid="b22">22</xref>,<xref ref-type="bibr" rid="b23">23</xref>,<xref ref-type="bibr" rid="b31">31</xref>,<xref ref-type="bibr" rid="b32">32</xref>). For EBP, this phenomenon has been attributed to a presumed later onset, with the latest reported age being 71 (<xref ref-type="bibr" rid="b5">5</xref>). Although the proband and her brother presented in childhood, their grandmother developed EBP at age 47, and their 46-year-old mother currently has no skin findings despite carrying the same mutation.</p>
      <p>The link between EBP and atopy is controversial. A history of atopy, in the probands themselves or in their relatives, might predispose some individuals to develop EBP instead of DEB, but genotypes associated with atopy such as filaggrin mutations and IL-31 polymorphisms are not consistently different between people with EBP and those with DEB (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b10">10</xref>). Some people with EBP have high IgE levels, but most have normal levels (<xref ref-type="bibr" rid="b3">3</xref>).</p>
      <p>Affected individuals can transition from a DEB to an EBP phenotype; most attribute this to the development of pruritus, which in turn causes the lesions of EBP (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b13">13</xref>&#x2013;<xref ref-type="bibr" rid="b15">15</xref>). This finding lends support to reports that question whether EBP is a unique disease entity or whether the phenotype is due to pruritus superimposed on DEB (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b5">5</xref>,<xref ref-type="bibr" rid="b31">31</xref>). Several cases in the literature suggest an initiating event for pruritus such as atopic dermatitis or allergies, thyroid dysfunction, and even varicella zoster virus infection (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b7">7</xref>). However, in most instances, no cause is found. Neither the index case nor her brother has atopy, and although their grandmother developed hypothyroidism in her 30s, she was clinically euthyroid at the time of her EBP eruption nearly 15 years later.</p>
      <p>EBP is notoriously challenging to treat (<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b30">30</xref>). Our patient was treated with numerous medications, including topical and systemic corticosteroids, antihistamines, anti-opiates, tumor necrosis factor alpha (TNF-&#x3B1;) inhibitors, and phototherapy with minimal success. Oral cyclosporine 5 mg/kg mildly improved her pruritus but was discontinued after 5 months because of marked gingival hyperplasia. Thalidomide has been documented to improve EBP, most likely through immunomodulation of the production of TNF-&#x3B1;, interferon gamma, and other cytokines (<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b21">21</xref>). Our patient was started on 100 mg/day of thalidomide and reported decreased pruritus and flattening of her lesions within 2 months. She developed mild peripheral neuropathy after 4 months of treatment, so the dose was decreased to 50 mg/day with resolution of her paresthesia and continued efficacy. After 9 months of thalidomide treatment, the proband&#x2019;s pruritus is well controlled, and her lesions continue to flatten, leaving hypopigmented macules and milia (<xref ref-type="fig" rid="fig06">Fig. 6</xref>).</p>
      <fig id="fig06" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Improvement of skin lesions with systemic thalidomide administration. The index case was started on thalidomide 100 mg daily and improved gradually with most apparent results at two months. Shins (A), left dorsal hand (B), and mid-upper back (C) show flattening of papules with less excoriation after 6 months of treatment.</p>
        </caption>
        <graphic xlink:href="pde0029-0725-f6"/>
      </fig>
      <p>This case demonstrates the phenotypic complexity and incomplete penetrance of <italic>COL7A1</italic> mutations in an extended kindred with DEB and EBP. The same mutation in intron 47, c.4668 + 1 G&gt;A, resulted in mild EBP in one individual, a severe but time-limited course in another, and no effect in yet another, but caused severe EBP in the proband that responded to thalidomide treatment after more than 10 years of trying alternative therapies. Additionally, the same mutation caused classic DEB with solely trauma-induced blistering in another branch of this family. Clinical studies and DNA sequencing for five common European variants of filaggrin and an <italic>MMP1</italic> promoter SNP failed to reveal the etiology of the proband&#x2019;s pruritus. Given that the observed mutation is predicted to affect splicing, one might speculate that alternative splice isoforms are expressed in different members of this kindred, though this would not explain the phenotypic variability seen in the majority of EBP kindreds carrying missense mutations. We expect that genetic and/or environmental factors are involved in the initiation and progression of EBP, although the exact mechanisms remain to be determined. Further elucidation may become permissible with broader availability of whole genome and transcriptome sequencing, and better understanding of common polymorphisms within the population that may contribute to the pathogenesis of pruritus and to EBP.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGrath</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schofield</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Eady</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features</article-title>
          <source>Br J Dermatol</source>
          <year>1994</year>
          <volume>130</volume>
          <fpage>617</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="pmid">8204470</pub-id>
        </element-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almaani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidermolysis bullosa pruriginosa in association with lichen planopilaris</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2009</year>
          <volume>34</volume>
          <fpage>e825</fpage>
          <lpage>e828</lpage>
          <pub-id pub-id-type="pmid">20055845</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drera</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Castiglia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zoppi</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dystrophic epidermolysis bullosa pruriginosa in Italy: clinical and molecular characterization</article-title>
          <source>Clin Genet</source>
          <year>2006</year>
          <volume>70</volume>
          <fpage>339</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="pmid">16965329</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ee</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Goh</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and molecular dilemmas in the diagnosis of familial epidermolysis bullosa pruriginosa</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2007</year>
          <volume>5</volume>
          <issue>Suppl</issue>
          <fpage>S77</fpage>
          <lpage>S81</lpage>
          <pub-id pub-id-type="pmid">17434045</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hozumi</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dystrophic epidermolysis bullosa pruriginosa of elderly onset</article-title>
          <source>J Dermatol</source>
          <year>2011</year>
          <volume>38</volume>
          <fpage>173</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">21269315</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Masunaga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa</article-title>
          <source>Arch Dermatol Res</source>
          <year>2000</year>
          <volume>292</volume>
          <fpage>477</fpage>
          <lpage>481</lpage>
          <pub-id pub-id-type="pmid">11142768</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schumann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Has</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kohlhase</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations</article-title>
          <source>Br J Dermatol</source>
          <year>2008</year>
          <volume>159</volume>
          <fpage>464</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">18565177</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Murrell</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa</article-title>
          <source>Exp Dermatol</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>553</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">18558993</pub-id>
        </element-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellerio</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ashton</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mohammedi</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa</article-title>
          <source>J Invest Dermatol</source>
          <year>1999</year>
          <volume>112</volume>
          <fpage>984</fpage>
          <lpage>987</lpage>
          <pub-id pub-id-type="pmid">10383749</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagy</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Techanukul</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Common IL-31 gene haplotype associated with non-atopic eczema is not implicated in epidermolysis bullosa pruriginosa</article-title>
          <source>Acta Derm Venereol</source>
          <year>2010</year>
          <volume>90</volume>
          <fpage>631</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="pmid">21057749</pub-id>
        </element-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broekaert</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Knauss-Scherwitz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Biedermann</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidermolysis bullosa pruriginosa due to a glycine substitution mutation in the COL7A1-gene</article-title>
          <source>Acta Derm Venereol</source>
          <year>2006</year>
          <volume>86</volume>
          <fpage>556</fpage>
          <lpage>557</lpage>
          <pub-id pub-id-type="pmid">17106611</pub-id>
        </element-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sawamura</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The G2028R glycine substitution mutation in leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa</article-title>
          <source>J Dermatol Sci</source>
          <year>2004</year>
          <volume>34</volume>
          <fpage>195</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">15113589</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pruneddu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Castiglia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Floriddia</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>COL7A1 Recessive mutations in two siblings with distinct subtypes of dystrophic epidermolysis bullosa: pruriginosa versus nails only</article-title>
          <source>Dermatology</source>
          <year>2011</year>
          <volume>222</volume>
          <fpage>10</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">21196708</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chuang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Martinez-Mir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel missense mutation in the COL7A1 gene underlies epidermolysis bullosa pruriginosa</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2004</year>
          <volume>29</volume>
          <fpage>304</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">15115517</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lapinski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lapiere</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Traczyk</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sporadic dystrophic epidermolysis bullosa with concomitant atopic dermatitis</article-title>
          <source>Br J Dermatol</source>
          <year>1998</year>
          <volume>138</volume>
          <fpage>315</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">9602882</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almaani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New glycine substitution mutations in type VII collagen underlying epidermolysis bullosa pruriginosa but the phenotype is not explained by a common polymorphism in the matrix metalloproteinase-1 gene promoter</article-title>
          <source>Acta Derm Venereol</source>
          <year>2009</year>
          <volume>89</volume>
          <fpage>6</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">19197535</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandilands</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Terron-Kwiatkowski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hull</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema</article-title>
          <source>Nat Genet</source>
          <year>2007</year>
          <volume>39</volume>
          <fpage>650</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="pmid">17417636</pub-id>
        </element-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Titeux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pendaries</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Tonasso</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa</article-title>
          <source>Hum Mutat</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>267</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="pmid">18030675</pub-id>
        </element-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banky</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Sheridan</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Storer</surname>
              <given-names>EL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus</article-title>
          <source>Arch Dermatol</source>
          <year>2004</year>
          <volume>140</volume>
          <fpage>794</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="pmid">15262686</pub-id>
        </element-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidermolysis bullosa pruriginosa (McGrath) successfully controlled by oral cyclosporin</article-title>
          <source>Br J Dermatol</source>
          <year>1997</year>
          <volume>137</volume>
          <fpage>308</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">9292092</pub-id>
        </element-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozanic</surname>
              <given-names>Bulic S</given-names>
            </name>
            <name>
              <surname>Fassihi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mellerio</surname>
              <given-names>JE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thalidomide in the management of epidermolysis bullosa pruriginosa</article-title>
          <source>Br J Dermatol</source>
          <year>2005</year>
          <volume>152</volume>
          <fpage>1332</fpage>
          <lpage>1334</lpage>
          <pub-id pub-id-type="pmid">15949003</pub-id>
        </element-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pulkkinen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa</article-title>
          <source>J Invest Dermatol</source>
          <year>1997</year>
          <volume>108</volume>
          <fpage>947</fpage>
          <lpage>949</lpage>
          <pub-id pub-id-type="pmid">9182828</pub-id>
        </element-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Klingberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marr</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants</article-title>
          <source>J Dermatol Sci</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>169</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">17425959</pub-id>
        </element-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A novel missense mutation in the COL7A1 gene causes epidermolysis bullosa pruriginosa</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2009</year>
          <volume>34</volume>
          <fpage>e975</fpage>
          <lpage>e978</lpage>
          <pub-id pub-id-type="pmid">19486043</pub-id>
        </element-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel splice site mutation in collagen type VII gene in a Chinese family with dominant dystrophic epidermolysis bullosa pruriginosa</article-title>
          <source>Acta Derm Venereol</source>
          <year>2002</year>
          <volume>82</volume>
          <fpage>187</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">12353709</pub-id>
        </element-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel missense mutation in COL7A1 in a Chinese pedigree with epidermolysis bullosa pruriginosa</article-title>
          <source>J Dermatol Sci</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>211</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="pmid">17336503</pub-id>
        </element-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ren</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>LY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A splicing mutation in the COL7A1 gene causes autosomal dominant dystrophic epidermolysis bullosa pruriginosa</article-title>
          <source>Br J Dermatol</source>
          <year>2008</year>
          <volume>158</volume>
          <fpage>618</fpage>
          <lpage>620</lpage>
          <pub-id pub-id-type="pmid">18067480</pub-id>
        </element-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Uitto</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa</article-title>
          <source>Dermatol Clin</source>
          <year>2010</year>
          <volume>28</volume>
          <fpage>93</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">19945621</pub-id>
        </element-citation>
      </ref>
      <ref id="b29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>PC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genotype-phenotype correlation in Chinese patients with dystrophic epidermolysis bullosa pruriginosa</article-title>
          <source>Acta Derm Venereol</source>
          <year>2012</year>
          <volume>92</volume>
          <fpage>50</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">21879237</pub-id>
        </element-citation>
      </ref>
      <ref id="b30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tey</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Almaani</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidermolysis bullosa pruriginosa masquerading as psychogenic pruritus</article-title>
          <source>Arch Dermatol</source>
          <year>2011</year>
          <volume>147</volume>
          <fpage>956</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">21844455</pub-id>
        </element-citation>
      </ref>
      <ref id="b31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murase</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kanoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa within the same family: two phenotypes associated with a COL7A1 mutation</article-title>
          <source>Acta Derm Venereol</source>
          <year>2011</year>
          <volume>91</volume>
          <fpage>730</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="pmid">21629976</pub-id>
        </element-citation>
      </ref>
      <ref id="b32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Covaciu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Grosso</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pisaneschi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A founder synonymous COL7A1 mutation in three Danish families with dominant dystrophic epidermolysis bullosa pruriginosa identifies exonic regulatory sequences required for exon 87 splicing</article-title>
          <source>Br J Dermatol</source>
          <year>2011</year>
          <volume>165</volume>
          <fpage>678</fpage>
          <lpage>682</lpage>
          <pub-id pub-id-type="pmid">21574979</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="supplementary-material">
      <title>Supporting Information</title>
      <supplementary-material content-type="loca-data" id="SD1">
        <caption>
          <p><bold>Table S1</bold> Reported EBP mutations organized by position within <italic>COL7A1</italic>.</p>
          <p><bold>Table S2</bold> Reported mutations causing recessive EBP</p>
        </caption>
        <media mimetype="pdf" mime-subtype="pdf" xlink:href="pde0029-0725-sd1.pdf" xlink:type="simple" id="d35e1618" position="anchor"/>
      </supplementary-material>
      <p>Please note: Wiley&#x2013;Blackwell are not responsible for thecontent or functionality of any supporting materials supplied bythe authors. Any queries (other than missing material) should bedirected to the corresponding author for the article.</p>
    </sec>
  </back>
</article>
</pmc-articleset>
